Your Wave Aesthetics provider will help you determine which medication is best suited for your needs
For example, Californias Medi-Cal program ended coverage of GLP-1 medications prescribed solely for weight loss effective January 1, 2026, regardless of manufacturer price reductions
10.1007/s00394-011-0284-2 22
10.1073/pnas.051551698 355
Are overweight (BMI greater than 27) with prediabetes or heart disease Have obesity (BMI greater than 30) and uncontrolled high blood pressure, kidney disease, or heart failure Have severe obesity (BMI greater than 35) These low prices will enable Medicare to cover Wegovy and Zepbound for patients with obesity and related comorbidities for the first time, according to the release
J Nutr 124:655663 Xia X, Yang H, Zhu X, Zhang L, Wang W (2013) Production method of yellow rice wine rich in reduced glutathione, and produced yellow rice wine